CLINICAL TRIALS PROFILE FOR DORZOLAMIDE HYDROCHLORIDE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for dorzolamide hydrochloride
Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|---|
New Formulation | NCT05857267 ↗ | Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety | Recruiting | Laboratorios Poen | Phase 4 | 2023-03-07 | The goal of this study is to evaluate the tolerability of the new formulation of Dorzolamide+Timolol preservative free developed in OSD Aptar Pharma multidose system in comparison with Dorzolamide +Timolol BAK preserved ophthalmic formulation. |
>Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for dorzolamide hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00108017 ↗ | Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2005-04-01 | This study is comparing 2 medications for glaucoma and how effective they are at controlling glaucoma over the course of an entire day. |
NCT00140049 ↗ | A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma | Completed | Pfizer | Phase 4 | 2005-07-01 | To demonstrate the statistical non inferiority of the combination of latanoprost and timolol given in the evening time once a day vs the combination of dorzamalide and timolol twice a day based on intraocular pressure measurements at 8 AM, 12 noon & 4 PM during a 12 week treatment. |
NCT00140049 ↗ | A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 4 | 2005-07-01 | To demonstrate the statistical non inferiority of the combination of latanoprost and timolol given in the evening time once a day vs the combination of dorzamalide and timolol twice a day based on intraocular pressure measurements at 8 AM, 12 noon & 4 PM during a 12 week treatment. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for dorzolamide hydrochloride
Condition Name
Clinical Trial Locations for dorzolamide hydrochloride
Trials by Country
Clinical Trial Progress for dorzolamide hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for dorzolamide hydrochloride
Sponsor Name